Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27975658 | 0.82 | LMNA (0.50) | HPGDLMNAMAPK1CYP2D6SRC | |
| SCHEMBL21140376 | 0.79 | TDP1 (0.48) | HPGDLMNAMAPK1CYP2D6SRC | |
| SCHEMBL5945426 | 0.78 | LMNA (0.46) | LMNAMAPK1CYP2D6SRCCES2 | |
| SCHEMBL4341343 | 0.78 | LMNA (0.46) | LMNAMAPK1CYP2D6SRCCES2 | |
| SCHEMBL3433198 | 0.75 | AKR1C3 (0.48) | HPGDLMNAMAPK1CYP2D6SRC | |
| SCHEMBL11721394 | 0.74 | TRPA1 (0.42) | HPGDLMNAMAPK1CYP2D6SRC | |
| SCHEMBL4641824 | 0.73 | TRPA1 (0.44) | HPGDLMNAMAPK1CYP2D6GLA | |
| SCHEMBL18943205 | 0.73 | TRPA1 (0.44) | HPGDLMNAMAPK1CYP2D6GLA | |
| SCHEMBL3647763 | 0.72 | HPGD (0.42) | HPGDLMNAMAPK1CYP2D6SRC | |
| SCHEMBL2121638 | 0.72 | LMNA (0.46) | LMNAMAPK1CYP2D6GLAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4539155-A | New peptide, process for preparation thereof and use thereof | FUISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1985-09-03 | — | — | US | claimed |
| EP-2981542-A1 | 2',4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX Pharmaceuticals, Inc. (US) | 2016-02-10 | — | — | EP | disclosed |
| EP-2970357-A1 | AMINO ACID PHOSPHORAMIDATE PRONUCLEOTIDES OF 2'-CYANO, AZIDO AND AMINO NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2970358-A1 | 3'-DEOXY NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2938624-A1 | D-ALANINE ESTER OF SP-NUCLEOSIDE ANALOG | IDENIX Pharmaceuticals, Inc. (US) | 2015-11-04 | — | — | EP | disclosed |
| EP-2935304-A1 | 4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX Pharmaceuticals, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-2920195-A1 | D-ALANINE ESTER OF RP-NUCLEOSIDE ANALOG | IDENIX Pharmaceuticals, Inc. (US) | 2015-09-23 | — | — | EP | disclosed |
| EP-2909222-A1 | 2',4'-BRIDGED NUCLEOSIDES FOR HCV INFECTION | IDENIX Pharmaceuticals, Inc. (US) | 2015-08-26 | — | — | EP | disclosed |
| EP-2909223-A1 | DINUCLEOTIDE COMPOUNDS FOR HCV INFECTION | IDENIX Pharmaceuticals, Inc. (US) | 2015-08-26 | — | — | EP | disclosed |
| EP-2906579-A1 | 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION | IDENIX Pharmaceuticals, Inc. (US) | 2015-08-19 | — | — | EP | disclosed |
| WO-2008082601-A2 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS | IDENIX PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | WO | disclosed |
| EP-1536804-A4 | 2'-C-METHYL-3'-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | IDENIX CAYMAN LTD (KY) | 2007-10-31 | — | — | EP | disclosed |
| EP-1809301-A2 | PREPARATION OF 2'FLUORO-2'-ALKYL-SUBSTITUTED OR OTHER OPTIONALLY SUBSTITUTED RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES | Pharmasset, Inc. (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1773856-A2 | PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2-FLUORO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES | Pharmasset, Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006031725-A2 | PREPARATION OF 2'FLUORO-2'- ALKYL- SUBSTITUTED OR OTHER OPTIONALLY SUBSTITUTED RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES | PHARMASSET, INC. (US) | 2006-03-23 | — | — | WO | disclosed |
| WO-2006012440-A2 | PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2-FLUORO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES | PHARMASSET, INC. (US) | 2006-02-02 | — | — | WO | disclosed |
| EP-1536804-A2 | 2'-C-METHYL-3'-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | Idenix (Cayman) Limited (KY) | 2005-06-08 | — | — | EP | disclosed |
| EP-1523489-A2 | MODIFIED 2' AND 3' -NUCLEOSIDE PRODUGS FOR TREATING FLAVIRIDAE INFECTIONS | Idenix (Cayman) Limited (KY) | 2005-04-20 | — | — | EP | disclosed |
| WO-2004002999-A2 | MODIFIED 2' AND 3' -NUCLEOSIDE PRODUGS FOR TREATING FLAVIRIDAE INFECTIONS | IDENIX (CAYMAN) LIMITED (KY) | 2004-01-08 | — | — | WO | disclosed |
| WO-2004002422-A2 | 2’-C-METHYL-3’-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | IDENIX (CAYMAN) LIMITED (KY) | 2004-01-08 | — | — | WO | disclosed |